Brisson Jacques, Bérubé Sylvie, Diorio Caroline, Sinotte Marc, Pollak Michael, Mâsse Benoît
Unité de recherche en Santé des Populations, Hôpital St-Sacrement du Centre hospitalier affilié universitaire de Québec, 1050 Chemin Sainte-Foy, Quebec, Canada.
Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):929-33. doi: 10.1158/1055-9965.EPI-06-0746.
Dietary vitamin D has been associated with lower mammographic breast density, a strong biomarker for breast cancer risk. Blood 25-hydroxyvitamin D [25(OH)D] is an integrated measure of vitamin D status (from food, supplements, and sun exposure) and varies with season. Our objective was to assess seasonal variations of breast density and compare such variations, if any, with that of 25(OH)D.
This cross-sectional study includes 741 premenopausal women recruited at screening mammography. Plasma 25(OH)D at recruitment was measured by RIA. Breast density was evaluated using a computer-assisted method. Seasonal variations were modeled using multivariate linear regression and semi-parametric cubic smoothing splines.
Season was strongly associated with 25(OH)D (P < 0.0001). The highest smoothed mean 25(OH)D levels were seen at the end of July (81.5 nmol/L) and the lowest in mid-April (52.4 nmol/L). Breast density showed modest seasonal variations (P = 0.028). The lowest smoothed mean breast density was observed in early December (38.5%) and the highest at the beginning of April (44.3%). When a 4-month lag time was presumed, seasonal variations of breast density appeared to be a mirror image of those of 25(OH)D, and the correlation of daily smoothed estimates of mean breast density and 25(OH)D was negative and strong (r = -0.90).
In premenopausal women, changes in blood vitamin D seem to be inversely related to changes in breast density with a lag time of about 4 months. This finding encourages further investigation of the possibility that vitamin D could reduce breast density and breast cancer risk.
膳食维生素D与较低的乳腺钼靶密度相关,乳腺钼靶密度是乳腺癌风险的一个重要生物标志物。血液25-羟维生素D[25(OH)D]是维生素D状态(来自食物、补充剂和阳光照射)的综合指标,且随季节变化。我们的目的是评估乳腺密度的季节性变化,并将这种变化(如果存在)与25(OH)D的变化进行比较。
这项横断面研究纳入了741名在乳腺钼靶筛查时招募的绝经前女性。招募时采用放射免疫分析法测定血浆25(OH)D。使用计算机辅助方法评估乳腺密度。采用多元线性回归和半参数三次平滑样条对季节性变化进行建模。
季节与25(OH)D密切相关(P<0.0001)。7月底观察到最高的平滑平均25(OH)D水平(81.5 nmol/L),4月中旬最低(52.4 nmol/L)。乳腺密度显示出适度的季节性变化(P = 0.028)。12月初观察到最低的平滑平均乳腺密度(38.5%),4月初最高(44.3%)。当假定有4个月的滞后时间时,乳腺密度的季节性变化似乎是25(OH)D变化的镜像,平均乳腺密度和25(OH)D的每日平滑估计值之间的相关性为负且很强(r = -0.90)。
在绝经前女性中,血液维生素D的变化似乎与乳腺密度的变化呈负相关,滞后时间约为4个月。这一发现促使人们进一步研究维生素D是否可以降低乳腺密度和乳腺癌风险。